Loading...
Please wait, while we are loading the content...
Role of inotuzumab ozogamicin in the treatment of relapsed/refractory acute lymphoblastic leukemia.
| Content Provider | Europe PMC |
|---|---|
| Author | George, Binsah Kantarjian, Hagop Jabbour, Elias Jain, Nitin |
| Copyright Year | 2016 |
| Related Links | https://europepmc.org/backend/ptpmcrender.fcgi?accid=PMC5618942&blobtype=pdf |
| ISSN | 1750743X |
| Volume Number | 8 |
| DOI | 10.2217/imt.15.108 |
| PubMed Central reference number | PMC5618942 |
| Issue Number | 2 |
| PubMed reference number | 26780449 |
| Journal | Immunotherapy |
| e-ISSN | 17507448 |
| Language | English |
| Publisher | Future Medicine Ltd |
| Publisher Date | 2016-01-18 |
| Publisher Place | London, UK |
| Access Restriction | Open |
| Rights License | © 2016 Future Medicine Ltd |
| Subject Keyword | acute lymphoblastic leukemia antibody drug conjugate inotuzumab monoclonal antibody |
| Content Type | Text |
| Resource Type | Article |
| Subject | Immunology and Allergy Immunology Oncology |